ABSTRACT
I began seeing CFS patients when I thought they had chronic mononucleosis, a rather uncommon disorder. They had negative Monospot tests, however. I began to treat them with H2-receptor antagonists, as I had previously done in those with acute infectious mononucleosis, a treatment still not part of mainstream medical care, although I have published its pharmacology in numerous journals and books. This discovery has lain fallow for so many years (since 1980) that I am even tired of complaining about it. H2-receptor antagonists can even treat pseudoseizures, a common neurosomatic problem (Sanne P et al., 1997).
